Rhythm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RHYTHM, and when can generic versions of RHYTHM drugs launch?
RHYTHM has one approved drug.
There are three US patents protecting RHYTHM drugs.
There are seventy-eight patent family members on RHYTHM drugs in twenty-one countries and seventeen supplementary protection certificates in eight countries.
Drugs and US Patents for Rhythm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | 9,458,195 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Rhythm | IMCIVREE | setmelanotide acetate | SOLUTION;SUBCUTANEOUS | 213793-001 | Nov 25, 2020 | RX | Yes | Yes | 11,129,869 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Rhythm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 101257916 | ⤷ Try a Trial |
Poland | 2286825 | ⤷ Try a Trial |
Hungary | E037147 | ⤷ Try a Trial |
South Korea | 20160020405 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Rhythm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2236151 | 21C1060 | France | ⤷ Try a Trial | PRODUCT NAME: SETMELANOTIDE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/21/1564 20210719 |
2236151 | 122021000084 | Germany | ⤷ Try a Trial | PRODUCT NAME: SETMELANOTID; REGISTRATION NO/DATE: EU/1/21/1564 20210716 |
2236151 | 2190056-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SETMELANOTID; REG. NO/DATE: EU/1/21/1564 20210719 |
2970389 | 301149 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SETMELANOTIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/21/1564 20210719 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.